Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures

REFERENCES

• Bekkergrob EWD, Essinkbot ML, Meerding WJ, et al. Patients' preferences for osteoporosis drug treatment: a discrete choice experiment. Arthritis Res Ther. 2014;19:1029–1037.
   Google Scholar
• Liu W, Zhou S, Wang S. Application of percutaneous vertebroplasty in the treatment of multiple thoracic metastases. Oncol Lett. 2015;9:2775.
   PubMed Web of Science ®Google Scholar
• Wardlaw D, Meirhaeghe JV, Ranstam J, et al. Balloon kyphoplasty in patients with osteoporotic vertebral compression fractures. Expert Rev Med Devices 2012;9:423–436.
   PubMed Web of Science ®Google Scholar
• Yu CW, Ming-Kai H, Chen LH, et al. Percutaneous balloon kyphoplasty for the treatment of vertebral compression fractures. BMC Surg. 2014;14:1–6.
   PubMed Web of Science ®Google Scholar
• Zhao G, Liu X, Li F. Balloon kyphoplasty versus percutaneous vertebroplasty for treatment of osteoporotic vertebral compression fractures (OVCFs). Osteoporos Int. 2016;27:1–12.
   Web of Science ®Google Scholar
• Yuan WH, Hsu HC, Lai KL. Vertebroplasty and balloon kyphoplasty versus conservative treatment for osteoporotic vertebral compression fractures: a meta-analysis. Medicine 2016;95:e4491.
   PubMed Web of Science ®Google Scholar
• Mansjur KQ, Kuroda S, Izawa T, et al. The effectiveness of human parathyroid hormone and low-intensity pulsed ultrasound on the fracture healing in osteoporotic bones. Ann Biomed Eng. 2016;44:2480–2488.
   PubMed Web of Science ®Google Scholar
• Semple D, Howlett M. A review of the USE of calcium liquid versus calcium tablets for maintaining corrected calcium levels. Arch Dis Child. 2016;101:e2.22–e22.
   Google Scholar
• Komm BS, Chines AA. An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis. Maturitas 2012;71:221–226.
   PubMed Web of Science ®Google Scholar
• Binkley N, Bone H, Gilligan JP, et al. Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial. Osteoporos Int. 2014;25:2649–2656.
   PubMed Web of Science ®Google Scholar
• Burden AM, Tadrous M, Calzavara A, et al. Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access. Osteoporos Int. 2015;26:1525–1533.
   PubMed Web of Science ®Google Scholar
• Häussler B, Gothe H, Göl D, et al. Epidemiology, treatment and costs of osteoporosis in Germany – the Bone EVA Study. Osteoporos Int. 2007;18:77–84.
   PubMed Web of Science ®Google Scholar
• Tarantino U, Capone A, Planta M, et al. P18 – the incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures: results of a three-year multicentre study. Clin Cases Mineral Bone Metabol. 2009;7:224.
   Google Scholar
• Lamy O, Uebelhart B, Aubry-Rozier B. Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures. Osteoporos Int. 2014;25:807–819.
   PubMed Web of Science ®Google Scholar
• Noriega DC, Ramajo RH, Lite IS, et al. Safety and clinical performance of kyphoplasty and SpineJack® procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study. Osteoporos Int. 2016;27:2047–2055.
   PubMed Web of Science ®Google Scholar
• Guo SM, Luo WJ, Huang YM, et al. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for osteoporotic vertebral compression fracture: a metaanalysis. Indian J Orthop. 2015;49:377–387.
   PubMed Web of Science ®Google Scholar
• Hasserius R, Karlsson MK, Jónsson B, et al. Long-term morbidity and mortality after a clinically diagnosed vertebral fracture in the elderly – a 12- and 22-year follow-up of 257 patients. Calcif Tissue Int. 2005;76:235.
   PubMed Web of Science ®Google Scholar
• Yan L, Jiang R, He B, et al. A comparison between unilateral transverse process-pedicle and bilateral puncture techniques in percutaneous kyphoplasty. Spine (Phila Pa 1976) 2014;39:S157–S164.
   Web of Science ®Google Scholar
• Berlemann U, Ferguson SJ, Nolte LP, et al. Adjacent vertebral failure after vertebroplasty. J Bone Joint Surg Br Vol. 2002;84:748–752.
   PubMed Web of Science ®Google Scholar
• Eriksen EF, Díez-Pérez A, Boonen S. Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review. Bone 2014;58:126.
   PubMed Web of Science ®Google Scholar
• Naylor KE, Jacques RM, Paggiosi M, et al. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int. 2016;27:21.
   PubMed Web of Science ®Google Scholar
• Silva PG, Ferreira Junior AE, Teófilo CR, et al. Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis. Arch Oral Biol. 2015;60:1237–1245.
   PubMed Web of Science ®Google Scholar
• Pataki A, Müller K, Green JR, et al. Effects of short‐term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec. 1997;249:458.
   PubMedGoogle Scholar
• Binkley N, Kimmel D, Bruner J, et al. Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys. J Bone Miner Res. 1998;13:1775–1782.
   PubMed Web of Science ®Google Scholar
• Dhillon S. Zoledronic acid (Reclast(®), Aclasta(®)): a review in osteoporosis. Drugs 2016;76:1683–1697.
   PubMed Web of Science ®Google Scholar
• Molvik H, Khan W. Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int. 2015;26:1251.
   PubMed Web of Science ®Google Scholar